Efficient tumor eradication by adoptively transferred cytotoxic T-cell clones in allogeneic hosts
Open Access
- 29 May 1996
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 66 (5) , 686-691
Abstract
Tumor‐specific cytotoxic T cells (CTLs) can play an important role against cancer as illustrated by the observation that adoptive transfer of tumor‐specific CTLs can mediate potent anti‐tumor effects. Although such CTLs can be detected at the tumor site, relatively little is known about the mechanisms by which they enter the tumor. In this study, the role of major histocompatibility complex (MHC) class I molecules on vascular endothelium in the tumor in entry of, and tumor eradication by, tumor‐specific CTL was investigated. Two H‐2Db‐restricted CTL clones recognizing peptide VNIRNCCYI on human adenovirus type 5 early region I‐(Ad5EI)‐induced tumors were used to test whether CTLs were able to cross the vascular endothelium lacking the restricting MHC molecule. One CTL clone recognizes peptide VNIRNCCYI in the context of both H‐2Db and H‐2Dbm14 molecules. The other CTL clone recognizes this peptide only in the context of H‐2Db. Adoptive transfer of these CTLs leads to eradication of Ad5EI‐induced, H‐2Db‐expressing tumors in B6 (H‐2Db+) and Bm14 (H‐2Db−) nude mice. Our data show that presentation of tumor‐derived peptides by MHC molecules on endothelial cells of blood vessels in a tumor do not play a major role in eradication of tumors by adoptively transferred CTL in combination with interleukin‐2. Moreover, our data show that successful adoptive CTL immunotherapy is possible across allogeneic barriers, without inducing severe side effects, provided the tumor expresses the MHC class I‐peptide complex recognized by the CTLs.Keywords
This publication has 26 references indexed in Scilit:
- High endothelial venules (HEVs): specialized endothelium for lymphocyte migrationImmunology Today, 1995
- Structure and function of adhesion receptors in leukocyte traffickingImmunology Today, 1995
- Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cellsEuropean Journal of Immunology, 1993
- Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia.Journal of Experimental Medicine, 1992
- Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC moleculesNature, 1991
- Dissection of an inflammatory process induced by CD8+ T cellsImmunology Today, 1990
- Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytesCell, 1989
- Heterogeneity of Lymphocyte Homing Physiology: Several Mechanisms Operate in the Control of Migration to Lymphoid and Non‐Lymphoid Organs In VivoImmunological Reviews, 1989
- Three spontaneous H-2Db mutants are generated by genetic micro-recombination (gene conversion) events. Impact on the H-2-restricted immune responsiveness.Journal of Experimental Medicine, 1988
- Immunogenetic analysis of cellular interactions governing the recruitment of T lymphocytes and monocytes in lymphocytic choriomeningitis virus-induced immunopathologyClinical Immunology and Immunopathology, 1988